Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2015

01-04-2015 | Original Article

Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy

Authors: Deirdre R. Pachman, Breanna L. Weisbrod, Drew K. Seisler, Debra L. Barton, Kelliann C. Fee-Schroeder, Thomas J. Smith, Daniel H. Lachance, Heshan Liu, Randy A. Shelerud, Andrea L. Cheville, Charles L. Loprinzi

Published in: Supportive Care in Cancer | Issue 4/2015

Login to get access
Metadata
Title
Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy
Authors
Deirdre R. Pachman
Breanna L. Weisbrod
Drew K. Seisler
Debra L. Barton
Kelliann C. Fee-Schroeder
Thomas J. Smith
Daniel H. Lachance
Heshan Liu
Randy A. Shelerud
Andrea L. Cheville
Charles L. Loprinzi
Publication date
01-04-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2424-8

Other articles of this Issue 4/2015

Supportive Care in Cancer 4/2015 Go to the issue

Original Article

Spiritual well-being among outpatients with cancer receiving concurrent oncologic and palliative care

Original Article

Worried together: a qualitative study of shared anxiety in patients with metastatic non-small cell lung cancer and their family caregivers

Original Article

The initial clinical interview—can it reduce cancer patients’ fear?

Original Article

Effect of endurance for adverse drug reactions on the preference for aggressive treatments in cancer patients

Original Article

Effects of unidentified renal insufficiency on the safety and efficacy of chemotherapy for metastatic colorectal cancer patients: a prospective, observational study

Original Article

The impact of hospice care on survival and cost saving among patients with liver cancer: a national longitudinal population-based study in Taiwan
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits